Fragment 176-191: Research Profile, Dosages & Supplier Prices
Fragment 176-191 is a metabolic research compound with a molecular weight of 1817.1 g/mol and a research half-life of short plasma half-life in published research. Fragment 176-191 is the C-terminal region of human growth hormone studied for isolating the fat-metabolism signaling of GH from its growth-promoting effects. It is one of the longest-selling research peptides in the metabolic category.
Research Use Only (RUO). Not for human or veterinary use. Not medical advice.
| Sequence | hGH residues 176-191 (Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met-Leu-Arg-Ile-Val-Gln-Cys-Arg) |
| Formula | C78H125N23O23S2 |
| Mol. weight | 1817.1 g/mol |
| Half-life | Short plasma half-life in published research |
| Forms sold | Lyophilized vial |
What is Fragment 176-191?
Published preclinical research examined lipolysis and fat oxidation models. Human data is limited compared to AOD-9604, which underwent formal clinical trials.
Quality note: the C-terminal cysteine makes Frag 176-191 prone to oxidation and dimerization - fresh synthesis dates and proper lyophilization matter. Check COA dates.
Mechanism of Action (Research Context)
Studied for lipolytic signaling attributed to the C-terminal region of hGH in animal models, without full GH receptor activation.
Research Areas
Fragment 176-191 Dosages in Research
Published preclinical research used microgram-to-milligram range dosing in animal models. Laboratory research use only.
Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.
Storage & Handling
Lyophilized: -20C, protect from moisture and oxygen exposure. Reconstituted: 2-8C, use promptly (oxidation-prone).
Fragment 176-191 Supplier Price Comparison
No tracked suppliers stock Fragment 176-191 yet — inventory syncs run continuously. Check our supplier reviews.